- Home
- /
- Treatment
- /
- Page 29
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Masitinib mesilate | Amyotrophic lateral sclerosis | AB Science | August 29, 2016 | |
Valproic Acid | McArdle’s disease | Vall d'Hebron Institute of Research | August 29, 2016 | |
9,10-dimethoxy-5,6-dihydro-[1,3] dioxolo[4,5-g]isoquinolino[3,2-alpha]isoquinolin-7-ium(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyhexadecahydro-1H-cyclopenta[alpha] | Primary sclerosing cholangitis | HighTide Biopharma Pty. Ltd.;1 Melissa Street;Mount Waverley | August 29, 2016 | |
Methotrexate | Alkaptonuria | aimAKU (Associazione Italiana Malati di Alcaptonuria) | August 29, 2016 | |
2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-alpha]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile | Idiopathic pulmonary fibrosis | Galapagos NV | August 29, 2016 | |
Venetoclax | Multiple myeloma | AbbVie Inc.;Regualtory Affairs, 1 North Waukegan Road;North Chicago, Illinois, 60064 | August 29, 2016 | |
Nintedanib | Systemic scleroderma | Boehringer Ingelheim International GmbH | August 29, 2016 | |
2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide | Scedosporiosis | F2G Ltd | August 29, 2016 | |
Recombinant protein derived from the saliva of theOrnithodoros moubatatick | Paroxysmal nocturnal hemoglobinuria | Akari Therapeutics Plc | August 29, 2016 | |
Anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single domain antibody | Pancreatic Cancer | Singh Biotechnology, LLC;4708 Rue Bordeaux;Lutz, Florida, 33558 | August 29, 2016 | |
Adenovirus associated viral vector serotype 5 containing the humanRPGRgene | Retinitis pigmentosa | MeiraGTx UK II Limited | August 29, 2016 | |
Sodium benzoate | Lysinuric protein intolerance | Lucane Pharma SA | August 29, 2016 | |
Recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1) | Primary sclerosing cholangitis | Acorda Therapeutics, Inc.;420 Saw Mill River Road;Ardsley, New York, 10502 | August 25, 2016 | |
Ublituximab | Neuromyelitis optica | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 25, 2016 | |
Phosphoinositide-3-kinase delta inhibitor | Chronic lymphocytic leukemia | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 23, 2016 | |
(1,3)-ß-D-glucan synthesis inhibitor | Invasive Aspergillus infections | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 | August 22, 2016 | |
Ambrisentan/tadalafil fixed combination | Pulmonary Arterial Hypertension | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | August 22, 2016 | |
Stabilized sulforaphane | Subarachnoid hemorrhage | Evgen Pharma PLC;146 Brownlow Hill;Liverpool | August 22, 2016 | |
Disufenton sodium | Glioblastoma | Oblato, Inc.;116 Village Boulevard;Princeton, New Jersey, 08540 | August 22, 2016 | |
Recombinant human interleukin-12 | Acute Radiation Syndrome Acute radiation syndrome | Neumedicines, Inc.;133 Altadena Drive, Suite 133;Pasadena, California, 91107 | August 22, 2016 | |
Live E. coli Nissle bacterium modified to assimilate ammonia | Urea cycle disorders | Synlogic, Inc.;200 Sidney Street, #320;Cambridge, Massachusetts, 02139 | August 22, 2016 | |
Etrolizumab | Ulcerative colitis | Genentech, Inc.;1 Dna Way;South San Francisco, California, 94080 | August 22, 2016 | |
Rituximab and recombinant human hyaluronidase | Chronic lymphocytic leukemia | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 | |
Rituximab and recombinant human hyaluronidase | Follicular lymphoma | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 | |
Cultured skin substitute (CSS) | Burns requiring skin grafting | Regenicin Inc.;10 High Court;Little Falls, New Jersey, 07424 | August 22, 2016 |